✦ LIBER ✦

Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

✍ Scribed by Maman, K.; Neine, M.; Briquet, B.; Nazir, J.; Odeyemi, I.A.O.; Hakimi, Z.; Garnham, A.; Aballéa, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Mirabegron Compare

✍ Aballéa, S.; Maman, K.; Desroziers, K.; Nazir, J.; Odeyemi, I.A.O.; Hakimi, Z.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PUK14 Cost-Effectiveness Analysis of Mir

✍ J. Xie; Z.Y. Zhou; C.N. Bui; Y. Yan; G. De; M.C. Runken; E.Q. Wu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PUK10 Cost-Effectiveness Analysis of Sol

✍ W.M. Hart; V. Munro; P. Retsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PUK20 A COST EFFECTIVENESS ANALYSIS OF S

✍ HH Kang; JY Bae; SY Park; HS Sohn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Risk Factors for the Failure of Antimusc

✍ Serati, Maurizio; Braga, Andrea; Siesto, Gabriele; Sorice, Paola; Cattoni, Elena 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Re: Risk Factors for the Failure of Anti

✍ Wein, Alan J. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 81 KB